IM Cannabis to Report Second Quarter 2025 Financial Results on Tuesday, August 12th at 9:00am ET

Rhea-AI Summary

IM Cannabis (NASDAQ: IMCC), a medical cannabis company operating in Israel and Germany, has scheduled its Q2 2025 financial results announcement for Tuesday, August 12, 2025, before market opening. The results will cover the period ended June 30, 2025.

News Market Reaction

+3.95%

3 alerts

+3.95% News Effect

-14.7% Trough Tracked

+$427K Valuation Impact

$11M Market Cap

0.9x Rel. Volume

On the day this news was published, IMCC gained 3.95%, reflecting a moderate positive market reaction. Argus tracked a trough of -14.7% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $427K to the company's valuation, bringing the market cap to $11M at that time.

Data tracked by StockTitan Argus on the day of publication.

TORONTO and GLIL YAM, Israel, Aug. 4, 2025 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter 2025 ended June 30, 2025, on Tuesday, August 12, 2025, before the market opens.

 

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company's focus is to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its subsidiaries, which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Company Contact:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com

Logo - https://mma.prnewswire.com/media/1742228/5439902/IM_Cannabis_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-second-quarter-2025-financial-results-on-tuesday-august-12th-at-900am-et-302520577.html

SOURCE IM Cannabis Corp.

FAQ

When will IM Cannabis (IMCC) report Q2 2025 earnings?

IM Cannabis will report Q2 2025 earnings on Tuesday, August 12, 2025, before the market opens.

What period will IM Cannabis Q2 2025 earnings cover?

The earnings report will cover the quarter ended June 30, 2025.

In which markets does IM Cannabis operate?

IM Cannabis operates in Israel and Germany as a medical cannabis company.

Where is IM Cannabis (IMCC) stock listed?

IM Cannabis stock is listed on the NASDAQ under the ticker symbol IMCC.